p.84 抽出テキスト

15. de Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the cardiovascular health study. Eur Heart J 2008;29:741–7. https://doi.org/10.1093/eurheartj/ehm605 16. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001;104:2039–44. https://doi.org/10. 1161/hc4201.097944 17. Hijazi Z, Verdecchia P, Oldgren J, Andersson U, Reboldi G, Di Pasquale G, et al. Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RE-LY trial. J Am Heart Assoc 2019;8: e010107. https://doi.org/10.1161/jaha.118.010107 18. Siedlinski M, Carnevale L, Xu X, Carnevale D, Evangelou E, Caulfield MJ, et al. Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure. Eur Heart J 2023;44:2114–25. https://doi.org/ 10.1093/eurheartj/ehad101 19. Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International 2021;99:S1–87. https://doi.org/10.1016/j.kint.2020.11.003 20. Subbiah A, Bhowmik D. KDIGO recommendations on blood pressure management in chronic kidney disease. Kidney Int 2022;101:1299. https://doi.org/10.1016/j.kint. 2022.02.036 21. Cheung CY, Biousse V, Keane PA, Schiffrin EL, Wong TY. Hypertensive eye disease. Nat Rev Dis Primers 2022;8:14. https://doi.org/10.1038/s41572-022-00342-0 22. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–13. https://doi.org/10.1016/ s0140-6736(02)11911-8 23. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200–4. https://doi.org/10.1161/01.Hyp.0000168052.00426.65 24. Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol 2018;258:257–61. https://doi.org/10.1016/j.ijcard.2017.12.086 25. Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan intervention for endpoint reduction in hypertension study. Hypertension 2008;51:1109–14. https://doi.org/10.1161/hypertensionaha.107.107474 26. Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial. Hypertension 2007;49:311–6. https://doi.org/10.1161/01.Hyp.0000254322.96189.85 27. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001;19:921–30. https://doi.org/10.1097/00004872-200105000-00013 28. Vasan RS, Pan S, Xanthakis V, Beiser A, Larson MG, Seshadri S, et al. Arterial stiffness and long-term risk of health outcomes: the Framingham heart study. Hypertension 2022;79:1045–56. https://doi.org/10.1161/hypertensionaha.121.18776 29. Piskorz D. Hypertensive mediated organ damage and hypertension management. How to assess beneficial effects of antihypertensive treatments? High Blood Press Cardiovasc Prev 2020;27:9–17. https://doi.org/10.1007/s40292-020-00361-6 30. Vallelonga F, Cesareo M, Menon L, Airale L, Leone D, Astarita A, et al. Cardiovascular hypertension-mediated organ damage in hypertensive urgencies and hypertensive outpatients. Front Cardiovasc Med 2022;9:889554. https://doi.org/10.3389/fcvm. 2022.889554 31. Vasan RS, Song RJ, Xanthakis V, Beiser A, DeCarli C, Mitchell GF, et al. Hypertension-mediated organ damage: prevalence, correlates, and prognosis in the community. Hypertension 2022;79:505–15. https://doi.org/10.1161/hypertensionaha. 121.18502 32. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet 2014;383: 1899–911. https://doi.org/10.1016/s0140-6736(14)60685-1 33. Malik R, Georgakis MK, Vujkovic M, Damrauer SM, Elliott P, Karhunen V, et al. Relationship between blood pressure and incident cardiovascular disease: linear and nonlinear Mendelian randomization analyses. Hypertension 2021;77:2004–13. https:// doi.org/10.1161/hypertensionaha.120.16534 34. Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol 2020;5:19–26. https:// doi.org/10.1001/jamacardio.2019.5306 35. Salles GF, Reboldi G, Fagard RH, Cardoso CRL, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension 2016;67:693–700. https://doi.org/10.1161/hypertensionaha.115.06981 36. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000;35:844–51. https://doi.org/10.1161/01.hyp. 35.3.844 37. Mauck GW, Smith CR, Geddes LA, Bourland JD. The meaning of the point of maximum oscillations in cuff pressure in the indirect measurement of blood pressure— part ii. J Biomech Eng 1980;102:28–33. https://doi.org/10.1115/1.3138195 38. Clark CE, Warren FC, Boddy K, McDonagh STJ, Moore SF, Goddard J, et al. Associations between systolic interarm differences in blood pressure and cardiovascular disease outcomes and mortality: individual participant data meta-analysis, development and validation of a prognostic algorithm: the INTERPRESS-IPD collaboration. Hypertension 2021;77:650–61. https://doi.org/10.1161/hypertensionaha.120.15997 39. Picone DS, Deshpande RA, Schultz MG, Fonseca R, Campbell NRC, Delles C, et al. Nonvalidated home blood pressure devices dominate the online marketplace in Australia: major implications for cardiovascular risk management. Hypertension 2020; 75:1593–9. https://doi.org/10.1161/hypertensionaha.120.14719 40. Picone DS, Campbell NRC, Schutte AE, Olsen MH, Ordunez P, Whelton PK, et al. Validation status of blood pressure measuring devices sold globally. JAMA 2022;327: 680–1. https://doi.org/10.1001/jama.2021.24464 41. Stergiou GS, O’Brien E, Myers M, Palatini P, Parati G, Kollias A, et al. STRIDE BP international initiative for accurate blood pressure measurement: systematic review of published validation studies of blood pressure measuring devices. J Clin Hypertens (Greenwich) 2019;21:1616–22. https://doi.org/10.1111/jch.13710 42. Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/ International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension 2018;71:368–74. https://doi.org/10.1161/hypertensionaha. 117.10237 43. Stergiou GS, Mukkamala R, Avolio A, Kyriakoulis KG, Mieke S, Murray A, et al. Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension working group on blood pressure monitoring and cardiovascular variability. J Hypertens 2022;40:1449–60. https://doi.org/10.1097/hjh.0000000000003224 44. Stergiou GS, Avolio AP, Palatini P, Kyriakoulis KG, Schutte AE, Mieke S, et al. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens 2023;41: 2074–87. https://doi.org/10.1097/hjh.0000000000003483 45. McAlister FA, Straus SE. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ 2001;322:908–11. https://doi.org/10. 1136/bmj.322.7291.908 46. Fagius J, Karhuvaara S. Sympathetic activity and blood pressure increases with bladder distension in humans. Hypertension 1989;14:511–7. https://doi.org/10.1161/01. hyp.14.5.511 47. Stergiou GS, Kyriakoulis KG, Stambolliu E, Destounis A, Karpettas N, Kalogeropoulos P, et al. Blood pressure measurement in atrial fibrillation: review and meta-analysis of evidence on accuracy and clinical relevance. J Hypertens 2019;37:2430–41. https://doi. org/10.1097/hjh.0000000000002201 48. Clark CE, McDonagh STJ, McManus RJ. Accuracy of automated blood pressure measurements in the presence of atrial fibrillation: systematic review and meta-analysis. J Hum Hypertens 2019;33:352–64. https://doi.org/10.1038/s41371-018-0153-z 49. Verberk WJ, Omboni S, Kollias A, Stergiou GS. Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations. Int J Cardiol 2016;203:465–73. https://doi.org/10.1016/j.ijcard.2015. 10.182 50. Manning DM, Kuchirka C, Kaminski J. Miscuffing: inappropriate blood pressure cuff application. Circulation 1983;68:763–6. https://doi.org/10.1161/01.cir.68.4.763 51. Irving G, Holden J, Stevens R, McManus RJ. Which cuff should I use? Indirect blood pressure measurement for the diagnosis of hypertension in patients with obesity: a diagnostic accuracy review. BMJ Open 2016;6:e012429. https://doi.org/10.1136/ bmjopen-2016-012429 52. Keeley EC, Villanueva M, Chen YE, Gong Y, Handberg EM, Smith SM, et al. Attended vs unattended systolic blood pressure measurement: a randomized comparison in patients with cardiovascular disease. J Clin Hypertens (Greenwich) 2020;22:1987–92. https://doi.org/10.1111/jch.14037 53. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011;342:d286. https:// doi.org/10.1136/bmj.d286 54. Clark CE. Inter-arm blood pressure difference, when is it a useful risk marker for cardiovascular events? J Hum Hypertens 2022;36:117–9. https://doi.org/10.1038/s41371- 021-00629-x 55. Clark CE, Steele AM, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL. Interarm blood pressure difference in people with diabetes: measurement and vascular and mortality implications: a cohort study. Diabetes Care 2014;37:1613–20. https://doi. org/10.2337/dc13-1576 56. Juraschek SP, Appel LJ, Mitchell CM, Mukamal KJ, Lipsitz LA, Blackford AL, et al. Comparison of supine and seated orthostatic hypotension assessments and their association with falls and orthostatic symptoms. J Am Geriatr Soc 2022;70:2310–9. https://doi.org/10.1111/jgs.17804

ESC Guidelines                                                                                                                                                                                          3995

Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026